374 related articles for article (PubMed ID: 21701228)
21. Predictive utility of apolipoprotein E genotype for Alzheimer disease in outpatients with mild cognitive impairment.
Devanand DP; Pelton GH; Zamora D; Liu X; Tabert MH; Goodkind M; Scarmeas N; Braun I; Stern Y; Mayeux R
Arch Neurol; 2005 Jun; 62(6):975-80. PubMed ID: 15956169
[TBL] [Abstract][Full Text] [Related]
22. Apolipoprotein E ε4 allele effects on longitudinal cognitive trajectories are sex and age dependent.
Williams OA; An Y; Armstrong NM; Shafer AT; Helphrey J; Kitner-Triolo M; Ferrucci L; Resnick SM
Alzheimers Dement; 2019 Dec; 15(12):1558-1567. PubMed ID: 31561966
[TBL] [Abstract][Full Text] [Related]
23. Apolipoprotein E4 is only a weak predictor of dementia and cognitive decline in the general population.
Yip AG; Brayne C; Easton D; Rubinsztein DC;
J Med Genet; 2002 Sep; 39(9):639-43. PubMed ID: 12205106
[TBL] [Abstract][Full Text] [Related]
24. APOE ε4 increases the risk of progression from amnestic mild cognitive impairment to Alzheimer's disease among ethnic Chinese in Taiwan.
Wang PN; Hong CJ; Lin KN; Liu HC; Chen WT
J Neurol Neurosurg Psychiatry; 2011 Feb; 82(2):165-9. PubMed ID: 20660919
[TBL] [Abstract][Full Text] [Related]
25. Association of
Qian J; Betensky RA; Hyman BT; Serrano-Pozo A
Neurology; 2021 May; 96(19):e2414-e2428. PubMed ID: 33771840
[TBL] [Abstract][Full Text] [Related]
26. ApoE and quality of life in nonagenarians.
Parsaik AK; Lapid MI; Rummans TA; Cha RH; Boeve BF; Pankratz VS; Tangalos EG; Petersen RC
J Am Med Dir Assoc; 2012 Oct; 13(8):704-7. PubMed ID: 22863665
[TBL] [Abstract][Full Text] [Related]
27. APOE epsilon4 and cognitive decline in older stroke patients with early cognitive impairment.
Ballard CG; Morris CM; Rao H; O'Brien JT; Barber R; Stephens S; Rowan E; Gibson A; Kalaria RN; Kenny RA
Neurology; 2004 Oct; 63(8):1399-402. PubMed ID: 15505155
[TBL] [Abstract][Full Text] [Related]
28. Stroke and apolipoprotein E epsilon4 are independent risk factors for cognitive decline: A population-based study.
Dik MG; Deeg DJ; Bouter LM; Corder EH; Kok A; Jonker C
Stroke; 2000 Oct; 31(10):2431-6. PubMed ID: 11022076
[TBL] [Abstract][Full Text] [Related]
29. Apolipoprotein E epsilon4, Alzheimer's disease, and cognitive performance in elderly Mexican Mestizos.
Villalpando-Berumen JM; Mejia-Arango S; Aguilar-Salinas CA; Ordonez-Sanchez ML; Gutierrez-Robledo LM
J Am Geriatr Soc; 2008 Apr; 56(4):677-82. PubMed ID: 18205760
[TBL] [Abstract][Full Text] [Related]
30. Association of
GoodSmith MS; Wroblewski KE; Schumm LP; McClintock MK; Pinto JM
Neurology; 2023 Sep; 101(13):e1341-e1350. PubMed ID: 37495381
[TBL] [Abstract][Full Text] [Related]
31. Apolipoprotein E genotype is not associated with cognitive impairment in older adults with bipolar disorder.
Kerr DS; Stella F; Radanovic M; Aprahamian I; Bertollucci PH; Forlenza OV
Bipolar Disord; 2016 Feb; 18(1):71-7. PubMed ID: 26877211
[TBL] [Abstract][Full Text] [Related]
32. Association between white matter hyperintensity severity and cognitive impairment according to the presence of the apolipoprotein E (APOE) ε4 allele in the elderly: retrospective analysis of data from the CREDOS study.
Son SJ; Lee KS; Lee Y; Baek JH; Choi SH; Na DL; Seo SW; Oh BH; Hong CH
J Clin Psychiatry; 2012 Dec; 73(12):1555-62. PubMed ID: 23146133
[TBL] [Abstract][Full Text] [Related]
33. APOE, MAPT, and SNCA genes and cognitive performance in Parkinson disease.
Mata IF; Leverenz JB; Weintraub D; Trojanowski JQ; Hurtig HI; Van Deerlin VM; Ritz B; Rausch R; Rhodes SL; Factor SA; Wood-Siverio C; Quinn JF; Chung KA; Peterson AL; Espay AJ; Revilla FJ; Devoto J; Hu SC; Cholerton BA; Wan JY; Montine TJ; Edwards KL; Zabetian CP
JAMA Neurol; 2014 Nov; 71(11):1405-12. PubMed ID: 25178429
[TBL] [Abstract][Full Text] [Related]
34. Memory complaints and APOE-epsilon4 accelerate cognitive decline in cognitively normal elderly.
Dik MG; Jonker C; Comijs HC; Bouter LM; Twisk JW; van Kamp GJ; Deeg DJ
Neurology; 2001 Dec; 57(12):2217-22. PubMed ID: 11756600
[TBL] [Abstract][Full Text] [Related]
35. Association Between Apolipoprotein E ε2 vs ε4, Age, and β-Amyloid in Adults Without Cognitive Impairment.
Insel PS; Hansson O; Mattsson-Carlgren N
JAMA Neurol; 2021 Feb; 78(2):229-235. PubMed ID: 33044487
[TBL] [Abstract][Full Text] [Related]
36. Apolipoprotein E genotypes in hospitalized elderly patients with vascular dementia.
Orsitto G; Seripa D; Panza F; Franceschi M; Cascavilla L; Placentino G; Matera MG; Paris F; Capurso C; Solfrizzi V; Dallapiccola B; Pilotto A
Dement Geriatr Cogn Disord; 2007; 23(5):327-33. PubMed ID: 17374951
[TBL] [Abstract][Full Text] [Related]
37. Vitamin B-12, apolipoprotein E genotype, and cognitive performance in community-living older adults: evidence of a gene-micronutrient interaction.
Feng L; Li J; Yap KB; Kua EH; Ng TP
Am J Clin Nutr; 2009 Apr; 89(4):1263-8. PubMed ID: 19244370
[TBL] [Abstract][Full Text] [Related]
38. APOE-ε4 Genotype and Dementia Before and After Transient Ischemic Attack and Stroke: Population-Based Cohort Study.
Pendlebury ST; Poole D; Burgess A; Duerden J; Rothwell PM;
Stroke; 2020 Mar; 51(3):751-758. PubMed ID: 32070224
[TBL] [Abstract][Full Text] [Related]
39. Effects of family history and apolipoprotein E epsilon4 status on cognitive decline in the absence of Alzheimer dementia: the Cache County Study.
Hayden KM; Zandi PP; West NA; Tschanz JT; Norton MC; Corcoran C; Breitner JC; Welsh-Bohmer KA;
Arch Neurol; 2009 Nov; 66(11):1378-83. PubMed ID: 19901170
[TBL] [Abstract][Full Text] [Related]
40. Apolipoprotein E Genotypes, Age, Race, and Cognitive Decline in a Population Sample.
Rajan KB; Barnes LL; Wilson RS; Weuve J; McAninch EA; Evans DA
J Am Geriatr Soc; 2019 Apr; 67(4):734-740. PubMed ID: 30584655
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]